[1] |
《中国关节病型银屑病诊疗共识(2020)》编写委员会专家组. 中国关节病型银屑病诊疗共识(2020)[J]. 中华皮肤科杂志, 2020,53(8):585⁃595. doi: 10.35541/cjd.20200369.
|
[2] |
Tascilar K, Bayindir O, Dogru A, et al. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis[J]. Br J Dermatol, 2021,184(6):1202⁃1203. doi: 10.1111/bjd.19826.
|
[3] |
Pittam B, Gupta S, Harrison NL, et al. Prevalence of extra⁃articular manifestations in psoriatic arthritis: a systematic review and meta⁃analysis[J]. Rheumatology (Oxford), 2020,59(9):2199⁃2206. doi: 10.1093/rheumatology/keaa062.
|
[4] |
Cohen JM, Husni ME, Qureshi AA, et al. Psoriatic arthritis: it′s as easy as "PSA"[J]. J Am Acad Dermatol, 2015,72(5):905⁃906. doi: 10.1016/j.jaad.2014.12.008.
|
[5] |
Husni ME, Meyer KH, Cohen DS, et al. The PASE questionnaire: pilot⁃testing a psoriatic arthritis screening and evaluation tool[J]. J Am Acad Dermatol, 2007,57(4):581⁃587. doi: 10.1016/j.jaad.2007.04.001.
|
[6] |
Colunga⁃Pedraza IJ, Galarza⁃Delgado DA, Azpiri⁃Lopez JR, et al. Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque[J]. Ann Rheum Dis, 2021,80(12):1629⁃1631. doi: 10.1136/annrheumdis⁃2021⁃220782.
|
[7] |
Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study[J]. Arthritis Rheum, 2006,54(8):2665⁃2673. doi: 10.1002/art.21972.
|
[8] |
Ibrahim G, Buch M, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire[J]. Clin Exp Rheumatol, 2009,27(3):469⁃474.
|
[9] |
Tom BD, Chandran V, Farewell VT, et al. Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2)[J]. J Rheumatol, 2015,42(5):841⁃846. doi: 10.3899/jrheum.140857.
|
[10] |
Tinazzi I, Adami S, Zanolin EM, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis[J]. Rheumatology (Oxford), 2012,51(11):2058⁃2063. doi: 10.1093/ rheumatology/kes187.
|
[11] |
Mishra S, Kancharla H, Dogra S, et al. Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study)[J]. Br J Dermatol, 2017,176(3):765⁃770. doi: 10.1111/bjd.14929.
|
[12] |
Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis[J]. J Am Acad Dermatol, 2003,49(2):206⁃212. doi: 10.1067/s0190⁃9622(03)00910⁃1.
|
[13] |
Cassell SE, Bieber JD, Rich P, et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis[J]. J Rheumatol, 2007,34(1):123⁃129.
|
[14] |
Augustin M, Blome C, Costanzo A, et al. Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes[J]. Br J Dermatol, 2014,170(3):591⁃598. doi: 10.1111/bjd.12664.
|
[15] |
Klaassen KM, van de Kerkhof PC, Bastiaens MT, et al. Scoring nail psoriasis[J]. J Am Acad Dermatol, 2014,70(6):1061⁃1066. doi: 10.1016/j.jaad.2014.02.010.
|
[16] |
夏萍, 卢传坚, 闫玉红. NAPPA⁃QOL中文版在甲银屑病患者应用中的信度和效度评价[J]. 中国皮肤性病学杂志, 2021,35(3):317⁃324.
|
[17] |
熊娟娟, 毕健平, 孙德祥, 等. 甲真菌病和甲银屑病的皮肤镜特征分析[J]. 中华皮肤科杂志, 2019,52(2):106⁃110. doi: 10.3760/cma.j.issn.0412⁃4030.2019.02.008.
|
[18] |
Abignano G, Laws P, Del Galdo F, et al. Three⁃dimensional nail imaging by optical coherence tomography: a novel biomarker of response to therapy for nail disease in psoriasis and psoriatic arthritis[J]. Clin Exp Dermatol, 2019,44(4):462⁃465. doi: 10. 1111/ced.13786.
|
[19] |
Long F, He F, Wang J, et al. Nailfold capillary abnormalities: a possible cause for nail psoriasis?[J]. Br J Dermatol, 2021,184(1):178⁃180. doi: 10.1111/bjd.19466.
|
[20] |
Mease PJ, Liu M, Rebello S, et al. Association of nail psoriasis with disease activity measures and impact in psoriatic arthritis: data from the corrona psoriatic arthritis/spondyloarthritis registry[J]. J Rheumatol, 2021,48(4):520⁃526. doi: 10.3899/jrheum. 190923.
|
[21] |
Tan AL, Benjamin M, Toumi H, et al. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis⁃⁃a high⁃resolution MRI and histological study[J]. Rheumatology (Oxford), 2007,46(2):253⁃256. doi: 10.1093/rheumatology/kel214.
|
[22] |
Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis[J]. N Engl J Med, 2017,376(10):957⁃970. doi: 10.1056/NEJMra150 5557.
|
[23] |
Perrin C. Histological evaluation of the relationships between distal interphalangeal psoriatic arthritis and nail psoriasis: correlations with anatomical studies of the normal nail unit and the main radiological data concerning distal interphalangeal psoriatic arthritis[J]. Am J Dermatopathol, 2020,42(12):911⁃915. doi: 10.1097/DAD.0000000000001786.
|
[24] |
Zabotti A, De Lucia O, Sakellariou G, et al. Predictors, risk factors, and incidence rates of psoriatic arthritis development in psoriasis patients: a systematic literature review and meta⁃analysis[J]. Rheumatol Ther, 2021,8(4):1519⁃1534. doi: 10.1007/s40744⁃021⁃00378⁃w.
|
[25] |
Antony AS, Allard A, Rambojun A, et al. Psoriatic nail dystrophy is associated with erosive disease in the distal interphalangeal joints in psoriatic arthritis: a retrospective cohort study[J]. J Rheumatol, 2019,46(9):1097⁃1102. doi: 10.3899/jrheum.180796.
|
[26] |
Scarpa R, Soscia E, Peluso R, et al. Nail and distal interphalangeal joint in psoriatic arthritis[J]. J Rheumatol, 2006,33(7):1315⁃1319.
|
[27] |
Moya Alvarado P, Roé Crespo E, Muñoz⁃Garza FZ, et al. Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease[J]. J Eur Acad Dermatol Venereol, 2018,32(10):1728⁃1736. doi: 10.1111/jdv.15035.
|
[28] |
Ash ZR, Tinazzi I, Gallego CC, et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails[J]. Ann Rheum Dis, 2012,71(4):553⁃556. doi: 10.1136/annrheumdis⁃2011⁃200478.
|
[29] |
Idolazzi L, Zabotti A, Fassio A, et al. The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions[J]. Clin Rheumatol, 2019,38(3):913⁃920. doi: 10.1007/s10067⁃019⁃04437⁃0.
|
[30] |
Errichetti E, Zabotti A, Stinco G, et al. Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis[J]. J Dermatol, 2016,43(10):1217⁃1220. doi: 10.1111/1346⁃8138.13438.
|
[31] |
Zabotti A, Errichetti E, Zuliani F, et al. Early psoriatic arthritis versus early seronegative rheumatoid arthritis: role of dermoscopy combined with ultrasonography for differential diagnosis[J]. J Rheumatol, 2018,45(5):648⁃654. doi: 10.3899/jrheum.170962.
|
[32] |
Asahina A, Fukuda T, Ishiuji Y, et al. Usefulness of dual⁃energy computed tomography for the evaluation of early⁃stage psoriatic arthritis only accompanied by nail psoriasis[J]. J Dermatol, 2017,44(12):e326⁃e327. doi: 10.1111/1346⁃8138.14008.
|
[33] |
Wiemann O, Werner SG, Langer HE, et al. The "green nail" phenomenon in ICG⁃enhanced fluorescence optical imaging ⁃ a potential tool for the differential diagnosis of psoriatic arthritis[J]. J Dtsch Dermatol Ges, 2019,17(2):138⁃147. doi: 10.1111/ddg.13747.
|
[34] |
Villani AP, Boutroy S, Coutisson C, et al. Distal phalangeal bone erosions observed by HR⁃pQCT in patients with psoriatic onycholysis[J]. Rheumatology (Oxford), 2021,60(3):1176⁃1184. doi: 10.1093/rheumatology/keaa415.
|